Danziger Asaf

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$809,539.20
Insider Sells Quantity
55
Insider Sells Sum
$258.09M

Insider Activity of Danziger Asaf

The largest purchase of all time was on 2021-11-26 and amounted to 4974 shares of NovoCure Limited for $509,539.

The largest sale of all time was on 2020-12-18 and amounted to 207910 shares of NovoCure Limited for $32.72M.

Biography of Danziger Asaf

No biography is available at this moment.

2023-01-05SaleNovoCure Limited
NVCR
Chief Executive Officer
212,000
0.1836%
$108.71$23.05M-65.87%
2021-11-26PurchaseNovoCure Limited
NVCR
Chief Executive Officer
4,974
0.0051%
$102.44$509,539-20.58%
2021-04-13SaleNovoCure Limited
NVCR
Chief Executive Officer
97,973
0.0942%
$196.34$19.24M-42.26%
2020-12-18SaleNovoCure Limited
NVCR
Chief Executive Officer
207,910
0.2004%
$157.39$32.72M-5.94%
2020-09-15SaleNovoCure Limited
NVCR
Chief Executive Officer
103,000
0.0964%
$99.00$10.2M+50.59%
2019-11-25SaleNovoCure Limited
NVCR
Chief Executive Officer
103,000
0.1063%
$95.00$9.79M-14.92%
2019-08-29SaleNovoCure Limited
NVCR
Chief Executive Officer
124,181
0.1254%
$91.13$11.32M-18%
2019-06-28SaleNovoCure Limited
NVCR
Chief Executive Officer
375,000
0.2133%
$34.65$12.99M+20.37%
2019-06-19SaleNovoCure Limited
NVCR
Chief Executive Officer
50,000
0.0308%
$36.46$1.82M+22.78%
2019-06-18SaleNovoCure Limited
NVCR
Chief Executive Officer
380,676
0.2436%
$36.87$14.04M+26.29%
2019-06-12SaleNovoCure Limited
NVCR
Chief Executive Officer
60,872
0.0627%
$55.39$3.37M+35.39%
2019-06-11SaleNovoCure Limited
NVCR
Chief Executive Officer
33,670
0.0352%
$54.75$1.84M+39%
2019-03-04SaleNovoCure Limited
NVCR
Chief Executive Officer
32,536
0.0363%
$55.89$1.82M+42.9%
2019-03-01SaleNovoCure Limited
NVCR
Chief Executive Officer
200,000
0.2089%
$55.57$11.11M+35.62%
2019-02-28SaleNovoCure Limited
NVCR
Chief Executive Officer
1,806
0.0019%
$54.40$98,237+41.16%
2019-02-13SaleNovoCure Limited
NVCR
Chief Executive Officer
35,804
0.0372%
$51.46$1.84M+43.58%
2019-02-12SaleNovoCure Limited
NVCR
Chief Executive Officer
32,098
0.0076%
$11.46$367,843+46%
2019-01-23SaleNovoCure Limited
NVCR
Chief Executive Officer
177,390
0.108%
$27.48$4.87M+48.6%
2019-01-18SaleNovoCure Limited
NVCR
Chief Executive Officer
93,726
0.0977%
$45.91$4.3M+49.62%
2019-01-17SaleNovoCure Limited
NVCR
Chief Executive Officer
200,000
0.1135%
$24.35$4.87M+53.4%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.